Who we are

SANIFIT is a biotechnology company focused on treatments for calcification disorders.

SANIFIT started activities in 2007 and has now operations in Spain and Switzerland.

read more

Leading drug candidate

SNF 472: For ESRD, hemodialysis patients

Patients with chronic kidney disease (CKD) suffer from accelerated calcification and increase rate of CV events. End stage renal disease (ESRD) patients require on dialysis and calcification is further accelerated, with an average life-expectancy of 5-6 years.

read more